Showing 2171-2180 of 3449 results for "".
Time in the Market: More Important Than Timing the Market
https://practicaldermatology.com/topics/practice-management/time-in-the-market-more-important-than-timing-the-market/20405/New Products and Therapeutics Focus: Hair and Nails
https://practicaldermatology.com/topics/practice-management/new-products-and-therapeutics-focus-hair-and-nails/20588/New products and pharmacologic developmentsNew Products
https://practicaldermatology.com/columns/new-products/new-products/20610/Marketing to Millennials: How to Reach This Influential Generation
https://practicaldermatology.com/topics/practice-management/marketing-to-millennials-how-to-reach-this-influential-generation/20596/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20594/It's Us Versus It
https://practicaldermatology.com/topics/practice-management/its-us-versus-it/20618/Are we entering a dermatologist-free zone?Is “Offshore” Asset Protection Right for You?
https://practicaldermatology.com/topics/practice-management/is-offshore-asset-protection-right-for-you/20649/What to do—and not to do—in international planning.How To (and How Not To) Build Your Email List
https://practicaldermatology.com/topics/practice-management/how-to-and-how-not-to-build-your-email-list/20636/In an era when we are all inundated with excess email, how can you convince people to subscribe to your newsletter and announcements?High-Dose Ipilimumab Shows Benefits in Advanced Melanoma: Implications for Care
https://practicaldermatology.com/topics/skin-cancer-photoprotection/high-dose-ipilimumab-shows-benefits-in-advanced-melanoma-implications-for-care/20687/Although treatment is associated with a high rate of toxicity, survival benefit is extended at a higher dose.A Non-Invasive 2-Gene Molecular Assay Shows Promise in Assessment of Pigmented Lesions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-non-invasive-2-gene-molecular-assay-shows-promise-in-assessment-of-pigmented-lesions/20705/More studies are needed, but a non-invasive assay that identified melanoma gene expression could support clinical decision making.